Inventor
NAIR SATHEESH KESAVAN
IN20 patents
⚠️ This page may combine multiple inventors who share the name “NAIR SATHEESH KESAVAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
19 patentsUS10294229B2May 21, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO9 citations84
US9862715B2Jan 9, 2018
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO5 citations83
US8987311B2Mar 24, 2015
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO14 citations83
US12286428B2Apr 29, 2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO2 citations74
US11267811B2Mar 8, 2022
Small molecule inhibitors of galectin-3
BRISTOL MYERS SQUIBB CO4 citations72
US9242975B2Jan 26, 2016
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO4 citations72
US11072626B2Jul 27, 2021
Small molecule inhibitors of Galectin-3
BRISTOL MYERS SQUIBB CO3 citations71
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US11053197B2Jul 6, 2021
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations62
US9242976B2Jan 26, 2016
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US11718601B2Aug 8, 2023
Pyridinyl substituted oxoisoindoline compounds
BRISTOL MYERS SQUIBB CO0 citations56
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US10676434B2Jun 9, 2020
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations51
US10266491B2Apr 23, 2019
Carbazole derivatives
BRISTOL MYERS SQUIBB CO0 citations51
US10227340B2Mar 12, 2019
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US12570659B2Mar 10, 2026
Bicyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US11970511B2Apr 30, 2024
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US10618903B2Apr 14, 2020
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO0 citations39